Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial

Principal Investigator

Principal Investigator

Johnson, William

Description

Description

The overall goal of this project is to conduct a therapeutic trial to assess the effect of docosahexaenoic acid (DHA) vs. placebo treatment on the global severity, behavioral symptoms, and functional ability of child and adolescent autistic disorder in a 12-week double-blind placebo-controlled parallel study. It contains three separate projects: conducting a double blind clinical trial; developing analytical assays for lipid biomarkers; genotyping GSTM1*0 and several genes related to DHA metabolism and testing whether the gene variants correlate with response to DHA treatment.

Funder

Funder

Department of Defense

Fiscal Year Funding

Fiscal Year Funding

0

Current Award Period

Current Award Period

na

Strategic Plan Question

Strategic Plan Question

Question 4: Which Treatments And Interventions Will Help?

Strategic Plan Objective

Strategic Plan Objective

Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Project Link

Project Link

Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial (External web link)

Institution

Institution

University of Medicine & Dentistry of New Jersey - Robert Wood Johnson Medical School

State/Country

State/Country

New Jersey

Project Number

Project Number

AS073084

Federal or Private?

Federal or Private?

Federal

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2009 | AS073084P2
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2009 | AS073084P1
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2010 | AS073084
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2010 | AS073084P2
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2010 | AS073084P1
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2011 | AS073084P1
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2011 | AS073084P2
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2011 | AS073084
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2012 | AS073084
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2012 | AS073084P1
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial | 0 | 2012 | AS073084P2

 
Back to Top